These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19434227)

  • 21. The baby with the bathwater.
    Buyske J
    Arch Surg; 2010 Jun; 145(6):577. PubMed ID: 20575190
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharma freebies for doctors linked to opioidprescribing habits.
    Vogel L
    CMAJ; 2019 Feb; 191(7):E202. PubMed ID: 30782649
    [No Abstract]   [Full Text] [Related]  

  • 23. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
    McCarthy M
    BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
    [No Abstract]   [Full Text] [Related]  

  • 25. New Swiss guidelines aim to curb big pharma's influence.
    Hyde R
    Lancet; 2013 Feb; 381(9865):441-2. PubMed ID: 23405415
    [No Abstract]   [Full Text] [Related]  

  • 26. Marketing pharmaceuticals: a constitutional right to sell prescriber-identified data?
    Gostin LO
    JAMA; 2012 Feb; 307(8):787-8. PubMed ID: 22357827
    [No Abstract]   [Full Text] [Related]  

  • 27. Small gifts sustain sales.
    Bausch J
    Dtsch Arztebl Int; 2010 Jun; 107(22):390-1. PubMed ID: 20574554
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Take this medicine: the legality of prescription incentive schemes.
    Fanning J; Glover-Thomas N
    Med Law Rev; 2010; 18(3):417-26. PubMed ID: 20739438
    [No Abstract]   [Full Text] [Related]  

  • 30. Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan.
    Saito H; Tani Y; Ozaki A; Sawano T; Shimada Y; Yamamoto K; Tanimoto T
    Clin Microbiol Infect; 2019 Nov; 25(11):1304-1306. PubMed ID: 31401175
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethics for the pediatrician: physician interaction with the pharmaceutical industry.
    Cicero MX; Curi MB; Mercurio M
    Pediatr Rev; 2011 Jan; 32(1):e1-3. PubMed ID: 21196498
    [No Abstract]   [Full Text] [Related]  

  • 33. Sunshine Has Darkened my Worldview.
    Alward WL
    Am J Ophthalmol; 2017 Mar; 175():xii-xiii. PubMed ID: 28088286
    [No Abstract]   [Full Text] [Related]  

  • 34. Physician Exposure to Direct-to-Consumer Pharmaceutical Marketing: Potential for Creating Prescribing Bias.
    Brown JL
    Am J Med; 2017 Jun; 130(6):e247-e248. PubMed ID: 28089801
    [No Abstract]   [Full Text] [Related]  

  • 35. The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide.
    Bandari J; Ayyash OM; Turner RM; Jacobs BL; Davies BJ
    Cancer; 2017 Nov; 123(22):4356-4362. PubMed ID: 28749536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Industry-to-physician marketing and the cost of prescription drugs.
    Chiong W
    Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480
    [No Abstract]   [Full Text] [Related]  

  • 37. US drug marketing: how does promotion correspond with health value?
    Greenway T; Ross JS
    BMJ; 2017 May; 357():j1855. PubMed ID: 28465309
    [No Abstract]   [Full Text] [Related]  

  • 38. The pharmaceutical industry: friend or foe?
    Niebyl JR
    Am J Obstet Gynecol; 2008 Apr; 198(4):435-9. PubMed ID: 18395035
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmaceuticals and Medical Devices: Business Practices.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-38. PubMed ID: 28252886
    [No Abstract]   [Full Text] [Related]  

  • 40. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
    Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
    BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.